Consistent with increased stemness in tumors, the stem cell marker Lgr5 was upregulated compared to normal cells, while colonic identity and differentiation genes such as Cdx2 and Krt20, were downregulated in both tumor types (50–58)(Figures 4A, B). This evidence concerns the gene CDX2 and neoplasm.